| 标题 |
Glofitamab vs. real-world regimens in Chinese patients with third- or later-line relapsed/refractory diffuse large B-cell lymphoma: an external control study |
| 网址 | |
| DOI |
10.20892/j.issn.2095-3941.2025.0104
doi
|
| 其它 |
期刊:Cancer biology and medicine 作者:Keshu Zhou; Huijing Wu; Xia Zhao; Xiaohong Tan; Xiaojing Yan; et al 出版日期:2025-09-30 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)